APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chemotherapy Induced Nausea and Vomiting (CINV) Drugs

Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families. In 1983, Coates et al. found that patients receiving chemotherapy ranked nausea and vomiting as the first and second most severe side effects, respectively. Up to 20% of patients receiving highly emetogenic agents in this era postponed, or even refused, potentially curative treatments. Since the 1990s, several novel classes of antiemetics have been developed and commercialized, becoming a nearly universal standard in chemotherapy regimens, and helping to better manage these symptoms in a large portion of patients. Efficient mediation of these unpleasant and sometimes crippling symptoms results in increased quality of life for the patient, and better overall health of the patient, and, due to better patient tolerance, more effective treatment cycles.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families. In 1983, Coates et al. found that patients receiving chemotherapy ranked nausea and vomiting as the first and second most severe side effects, respectively. Up to 20% of patients receiving highly emetogenic agents in this era postponed, or even refused, potentially curative treatments. Since the 1990s, several novel classes of antiemetics have been developed and commercialized, becoming a nearly universal standard in chemotherapy regimens, and helping to better manage these symptoms in a large portion of patients. Efficient mediation of these unpleasant and sometimes crippling symptoms results in increased quality of life for the patient, and better overall health of the patient, and, due to better patient tolerance, more effective treatment cycles.

Selected research

Industry Research

Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Research Report 2026

21 December 2025126 pages

Choose your research edition.

Industry ResearchChemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families. In 1983, Coates et al. found that patients receiving chemotherapy ranked nausea and vomiting as the first and second most severe side effects, respectively. Up to 20% of patients receiving highly emetogenic agents in this era postponed, or even refused, potentially curative treatments. Since the 1990s, several novel classes of antiemetics have been developed and commercialized, becoming a nearly universal standard in chemotherapy regimens, and helping to better manage these symptoms in a large portion of patients. Efficient mediation of these unpleasant and sometimes crippling symptoms results in increased quality of life for the patient, and better overall health of the patient, and, due to better patient tolerance, more effective treatment cycles.

Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs key players include Merck, Eisai, Mundipharma, etc. Global top three manufacturers hold a share over 50%.

North America is the largest market, with a share about 50%, followed by China, and Europe both have a share about 35 percent.

Read the full market overview

In terms of product, 5-HT3 Inhibitors is the largest segment, with a share over 60%. And in terms of application, the largest application is Moderately Emetogenic Chemotherapy, followed by Highly Emetogenic Chemotherapy, Low Emetogenic Chemotherapy, etc.

Report Scope

This report quantifies the global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market by Company

Merck

Eisai

Mundipharma

Qilu Pharma

Teva

Novartis

Heron Therapeutics

Roche

Mylan

Tesaro

Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Segment by Type

5-HT3 Inhibitors

NK1 Inhibitors

Other

Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Segment by Application

Highly Emetogenic Chemotherapy

Moderately Emetogenic Chemotherapy

Low Emetogenic Chemotherapy

Other

Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Manufacturers (2021-2026) Table 8. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue of Manufacturers (2021-2026) Table 9. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Average Price (USD/Unit) of Manufacturers (2021-2026) Table 11. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs, Product Type & Application Table 14. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Merck Company Information Table 19. Merck Business Overview Table 20. Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 21. Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio Table 22. Merck Recent Developments Table 23. Eisai Company Information Table 24. Eisai Business Overview Table 25. Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 26. Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio Table 27. Eisai Recent Developments Table 28. Mundipharma Company Information Table 29. Mundipharma Business Overview Table 30. Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 31. Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio Table 32. Mundipharma Recent Developments Table 33. Qilu Pharma Company Information Table 34. Qilu Pharma Business Overview Table 35. Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 36. Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio Table 37. Qilu Pharma Recent Developments Table 38. Teva Company Information Table 39. Teva Business Overview Table 40. Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 41. Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio Table 42. Teva Recent Developments Table 43. Novartis Company Information Table 44. Novartis Business Overview Table 45. Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 46. Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio Table 47. Novartis Recent Developments Table 48. Heron Therapeutics Company Information Table 49. Heron Therapeutics Business Overview Table 50. Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 51. Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio Table 52. Heron Therapeutics Recent Developments Table 53. Roche Company Information Table 54. Roche Business Overview Table 55. Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 56. Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio Table 57. Roche Recent Developments Table 58. Mylan Company Information Table 59. Mylan Business Overview Table 60. Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 61. Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio Table 62. Mylan Recent Developments Table 63. Tesaro Company Information Table 64. Tesaro Business Overview Table 65. Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 66. Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio Table 67. Tesaro Recent Developments Table 68. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 69. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region (2021-2026) & (K Units) Table 70. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Region (2021-2026) Table 71. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region (2027-2032) & (K Units) Table 72. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Region (2027-2032) Table 73. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Region (2021-2026) & (US$ Million) Table 74. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Region (2021-2026) Table 75. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Region (2027-2032) & (US$ Million) Table 76. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Region (2027-2032) Table 77. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2021-2026) & (K Units) Table 79. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2027-2032) & (K Units) Table 80. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2021-2026) & (US$ Million) Table 81. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2027-2032) & (US$ Million) Table 82. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2021-2026) & (K Units) Table 84. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2027-2032) & (K Units) Table 85. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2021-2026) & (US$ Million) Table 86. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2027-2032) & (US$ Million) Table 87. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2021-2026) & (K Units) Table 89. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2027-2032) & (K Units) Table 90. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2021-2026) & (US$ Million) Table 91. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2027-2032) & (US$ Million) Table 92. South America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. South America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2021-2026) & (K Units) Table 94. South America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2027-2032) & (K Units) Table 95. South America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2021-2026) & (US$ Million) Table 96. South America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2027-2032) & (US$ Million) Table 97. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2021-2026) & (K Units) Table 99. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2027-2032) & (K Units) Table 100. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2021-2026) & (US$ Million) Table 101. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2027-2032) & (US$ Million) Table 102. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2021-2026) & (K Units) Table 103. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2027-2032) & (K Units) Table 104. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type (2021-2026) Table 105. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type (2027-2032) Table 106. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Type (2021-2026) & (US$ Million) Table 107. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Type (2027-2032) & (US$ Million) Table 108. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Type (2021-2026) Table 109. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Type (2027-2032) Table 110. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price by Type (2021-2026) & (USD/Unit) Table 111. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price by Type (2027-2032) & (USD/Unit) Table 112. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2021-2026) & (K Units) Table 113. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2027-2032) & (K Units) Table 114. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2021-2026) Table 115. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2027-2032) Table 116. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Application (2021-2026) & (US$ Million) Table 117. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Application (2027-2032) & (US$ Million) Table 118. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Application (2021-2026) Table 119. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Application (2027-2032) Table 120. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price by Application (2021-2026) & (USD/Unit) Table 121. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price by Application (2027-2032) & (USD/Unit) Table 122. Key Raw Materials Table 123. Raw Materials Key Suppliers Table 124. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Distributors List Table 125. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Customers List Table 126. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Trends Table 127. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Drivers Table 128. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Restraints Table 129. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Image Figure 5. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size (2021-2032) & (US$ Million) Figure 7. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (2021-2032) & (K Units) Figure 8. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Average Price (USD/Unit) & (2021-2032) Figure 9. 5-HT3 Inhibitors Product Image Figure 10. NK1 Inhibitors Product Image Figure 11. Other Product Image Figure 12. Highly Emetogenic Chemotherapy Product Image Figure 13. Moderately Emetogenic Chemotherapy Product Image Figure 14. Low Emetogenic Chemotherapy Product Image Figure 15. Other Product Image Figure 16. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region in 2025 Figure 22. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Region in 2025 Figure 23. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Country in 2025 Figure 24. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Country (2021-2032) Figure 25. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Country (2021-2032) Figure 26. United States Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Country in 2025 Figure 30. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Country (2021-2032) Figure 31. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Country (2021-2032) Figure 32. Germany Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Country in 2025 Figure 43. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Country (2021-2032) Figure 45. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Country in 2025 Figure 54. South America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Country (2021-2032) Figure 55. South America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Country (2021-2032) Figure 56. Brazil Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Colombia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Country in 2025 Figure 61. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Country (2021-2032) Figure 62. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Country (2021-2032) Figure 63. Egypt Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. South Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Israel Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Türkiye Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. GCC Countries Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type (2021-2032) Figure 69. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Type (2021-2032) Figure 70. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price (USD/Unit) by Type (2021-2032) Figure 71. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2021-2032) Figure 72. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Application (2021-2032) Figure 73. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price (USD/Unit) by Application (2021-2032) Figure 74. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Value Chain Figure 75. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Opportunities and Challenges

Scope & coverage.

Types
  • 5-HT3 Inhibitors
  • NK1 Inhibitors
  • Other
Applications
  • Highly Emetogenic Chemotherapy
  • Moderately Emetogenic Chemotherapy
  • Low Emetogenic Chemotherapy
  • Other
Companies covered
  • Merck
  • Eisai
  • Mundipharma
  • Qilu Pharma
  • Teva
  • Novartis
  • Heron Therapeutics
  • Roche
  • Mylan
  • Tesaro

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size (2021-2032)
  4. 2.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (2021-2032)
  5. 2.2.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Average Price (2021-2032)
  6. 2.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 5-HT3 Inhibitors
  9. 2.3.3 NK1 Inhibitors
  10. 2.3.4 Other
  11. 2.4 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Highly Emetogenic Chemotherapy
  14. 2.4.3 Moderately Emetogenic Chemotherapy
  15. 2.4.4 Low Emetogenic Chemotherapy
  16. 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs, Product Type & Application
  8. 3.8 Global Manufacturers of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs, Established Date
  9. 3.9 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Merck
  2. 4.1.1 Merck Company Information
  3. 4.1.2 Merck Business Overview
  4. 4.1.3 Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
  6. 4.1.5 Merck Recent Developments
  7. 4.2 Eisai
  8. 4.2.1 Eisai Company Information
  9. 4.2.2 Eisai Business Overview
  10. 4.2.3 Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
  12. 4.2.5 Eisai Recent Developments
  13. 4.3 Mundipharma
  14. 4.3.1 Mundipharma Company Information
  15. 4.3.2 Mundipharma Business Overview
  16. 4.3.3 Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
  18. 4.3.5 Mundipharma Recent Developments
  19. 4.4 Qilu Pharma
  20. 4.4.1 Qilu Pharma Company Information
  21. 4.4.2 Qilu Pharma Business Overview
  22. 4.4.3 Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
  24. 4.4.5 Qilu Pharma Recent Developments
  25. 4.5 Teva
  26. 4.5.1 Teva Company Information
  27. 4.5.2 Teva Business Overview
  28. 4.5.3 Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
  30. 4.5.5 Teva Recent Developments
  31. 4.6 Novartis
  32. 4.6.1 Novartis Company Information
  33. 4.6.2 Novartis Business Overview
  34. 4.6.3 Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
  36. 4.6.5 Novartis Recent Developments
  37. 4.7 Heron Therapeutics
  38. 4.7.1 Heron Therapeutics Company Information
  39. 4.7.2 Heron Therapeutics Business Overview
  40. 4.7.3 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
  42. 4.7.5 Heron Therapeutics Recent Developments
  43. 4.8 Roche
  44. 4.8.1 Roche Company Information
  45. 4.8.2 Roche Business Overview
  46. 4.8.3 Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
  48. 4.8.5 Roche Recent Developments
  49. 4.9 Mylan
  50. 4.9.1 Mylan Company Information
  51. 4.9.2 Mylan Business Overview
  52. 4.9.3 Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
  54. 4.9.5 Mylan Recent Developments
  55. 4.10 Tesaro
  56. 4.10.1 Tesaro Company Information
  57. 4.10.2 Tesaro Business Overview
  58. 4.10.3 Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio
  60. 4.10.5 Tesaro Recent Developments
5 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Scenario by Region
  1. 5.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region: 2021-2032
  3. 5.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region: 2021-2026
  4. 5.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region: 2027-2032
  5. 5.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Region: 2021-2032
  6. 5.3.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Region: 2021-2026
  7. 5.3.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Region: 2027-2032
  8. 5.4 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures by Country
  9. 5.4.1 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2021-2032)
  11. 5.4.3 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures by Country
  16. 5.5.1 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2021-2032)
  18. 5.5.3 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures by Country
  41. 5.7.1 South America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2021-2032)
  43. 5.7.3 South America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2021-2032)
  2. 6.1.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type (2021-2032)
  4. 6.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Type (2021-2032)
  5. 6.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2021-2032)
  2. 7.1.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2021-2032)
  4. 7.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Application (2021-2032)
  5. 7.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Value Chain Analysis
  2. 8.1.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Production Mode & Process
  5. 8.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Distributors
  8. 8.2.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Customers
9 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Analyzing Market Dynamics
  1. 9.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Trends
  2. 9.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Drivers
  3. 9.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Opportunities and Challenges
  4. 9.4 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst